amdinocillin has been researched along with clavulanic acid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, TW; Ishida, N; Maiti, SN; Micetich, RG; Nakai, A; Ogawa, K; Spevak, P; Tanaka, M; Yamabe, S; Yamazaki, T | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Houben, AW; Stobberingh, EE; van Boven, CP | 1 |
| Marre, R; Schulz, E | 1 |
| Frère, JM; Ghuysen, JM; Kelly, JA; Klein, D | 1 |
| Howells, CH; Menday, AP; O'Dowd, TC; Ribeiro, CD; Smail, JE | 1 |
| Livermore, D; Thomas, K; Warner, M; Weinbren, MJ; Woodford, N | 1 |
| Andrews, J; Brenwald, NP; Fraise, AP | 1 |
| Galani, I; Giamarellou, H; Katsarolis, I; Lampri, N; Petrikkos, G; Poulakou, G; Souli, M | 1 |
| Aberrane, S; Bechet, S; Beraud, L; Bidet, P; Birgy, A; Bonacorsi, S; Cohen, R; Cointe, A; Cuzon, G; Desmarest, M; Dommergues, MA; Ferroni, A; Gajdos, V; Haas, H; Hobson, CA; Jung, C; Launay, E; Levy, C; Madhi, F; Pinquier, D; Sobral, E; Vuthien, H | 1 |
1 trial(s) available for amdinocillin and clavulanic acid
| Article | Year |
|---|---|
A comparative trial of pivmecillinam/pivampicillin and amoxycillin/clavulanate in the therapy of urinary tract infection in a general practice population.
Topics: Adult; Aged; Amdinocillin; Amdinocillin Pivoxil; Amoxicillin; Ampicillin; Bacteriuria; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Escherichia coli Infections; Female; Humans; Middle Aged; Pivampicillin; Random Allocation | 1984 |
10 other study(ies) available for amdinocillin and clavulanic acid
| Article | Year |
|---|---|
Synthesis and beta-lactamase inhibitory properties of 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Penicillanic Acid; Sulbactam; Tazobactam; Triazoles | 1987 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activity of ampicillin alone and in combination with different concentrations of 6 beta-bromopenicillanic acid, clavulanic acid and mecillinam.
Topics: Amdinocillin; Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Interactions; Drug Synergism; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillanic Acid | 1987 |
In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.
Topics: Amdinocillin; Amoxicillin; beta-Lactamases; Chromosomes, Bacterial; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Escherichia coli; Microbial Sensitivity Tests | 1988 |
Interaction between non-classical beta-lactam compounds and the Zn2+-containing G and serine R61 and R39 D-alanyl-D-alanine peptidases.
Topics: Actinomycetaceae; Amdinocillin; beta-Lactams; Carboxypeptidases; Cefoxitin; Cephalosporins; Clavulanic Acid; Drug Interactions; Endopeptidases; Enzyme Inhibitors; Imipenem; Kinetics; Penicillanic Acid; Penicillins; Quinoxalines; Serine-Type D-Ala-D-Ala Carboxypeptidase; Streptomyces; Zinc | 1981 |
Activity of mecillinam against ESBL producers in vitro.
Topics: Amdinocillin; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillins | 2006 |
Activity of mecillinam against AmpC beta-lactamase-producing Escherichia coli.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Boronic Acids; Clavulanic Acid; Drug Therapy, Combination; Escherichia coli; Microbial Sensitivity Tests; Thiophenes | 2006 |
Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactamases; Clavulanic Acid; Community-Acquired Infections; DNA, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Greece; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Urinary Tract Infections | 2012 |
Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with blaOXA-1 in a paediatric population with febrile urinary tract infections.
Topics: Amdinocillin; Anti-Bacterial Agents; Cefixime; Cefpodoxime; Ceftizoxime; Child; Clavulanic Acid; Humans; Urinary Tract Infections | 2021 |